MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Interius BioTherapeutics, Inc.
Organization & Developments: Interius BioTherapeutics
Parents
Interius BioTherapeutics, Inc.
Children
*Developer of gene delivery platform to treat hematologic malignancies and other cancers.
*Platform develops chimeric antigen receptor T cells directly in vivo bypassing the need for ex vivo cell manipulations required for standard CAR T-cell treatments
2024: First Patient Dosed with In Vivo Gene Therapy for CAR T
Jumps
Finance & Acquisition: Interius BioTherapeutics
Key People: Interius BioTherapeutics